- Neogen posted a fiscal third-quarter net loss of $17 million, widening from year-ago levels; diluted loss per share was $0.08.
- Revenue fell 4.4% to $211.2 million, reflecting a 20.1% drop in Animal Safety sales to $54.5 million on third-party supplier issues.
- Adjusted EBITDA edged down to $48.2 million from year-ago levels, while Food Safety revenue rose 2.6% to $156.7 million.
- Neogen advanced its Petrifilm manufacturing transition, with validation completed on 100% of equipment and completion still targeted for November 2026.
- Full-year revenue outlook increased to $857 million-$860 million, while adjusted EBITDA guidance was maintained at approximately $175 million.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neogen Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20260409479304) on April 09, 2026, and is solely responsible for the information contained therein.
Comments